Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study-Reference-Cited by-同舟云学术

Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study

Published:2018-10 Issue:10 Volume:41 Page:1322-1327
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Berwanger Otavio¹^ORCID,Abdelhamid Magdy²,Alexander Thomas³,Alzubaidi Abdulmajeed⁴,Averkov Oleg⁵,Aylward Philip⁶,Contreras Zúñiga Eduardo⁷,Halvorsen Sigrun⁸,Iglesias Ricardo⁹,A. SK. Abdul Kader Muhamad¹⁰,Zubaid Mohammad¹¹,AlHabib Khalid F.¹²

Affiliation:

1. Hospital do Coração; São Paulo Brazil

2. Cairo University; Cairo Egypt

3. Kovai Medical Centre; Coimbatore India

4. Sheikh Khalifa Medical City; Abu Dhabi UAE

5. Pirogov Russian National Research Medical University; Moscow Russia

6. South Australian Health and Medical Research Institute, Flinders University and Medical Centre; Adelaide Australia

7. Clinica de Occidente; Santiago de Cali Colombia

8. Oslo University Hospital; Ullevål Norway

9. Sanatorio Trinidad Mitre; Buenos Aires Argentina

10. Penang Hospital; Pulau Pinang Malaysia

11. Kuwait University; Kuwait City Kuwait

12. Department of Cardiac Sciences; King Fahad Cardiac Centre, College of Medicine, King Saud University; Riyadh Saudi Arabia

Funder

AstraZeneca

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.23043/fullpdf

Reference32 articles.

1. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;Circulation,2013

2. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC);Ibanez;Eur Heart J,2018

3. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction;Armstrong;N Engl J Med,2013

4. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour;Boersma;Lancet,1996

5. Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials;Roule;Crit Care,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysis;ARYA ATHEROSCLER;2024

2. Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST ‐segment elevation myocardial infarction;Clinical Cardiology;2021-08-18

3. Successful Intravenous Thrombolysis and Endovascular Treatment for Acute Ischemic Stroke in a Patient Pretreated with Ticagrelor: A Case Report and Literature Review;Clinical Drug Investigation;2021-06-09

4. Stroke Thrombolysis in Patients Taking Ticagrelor –Two Successful Cases and a Review of the Literature;Journal of Stroke and Cerebrovascular Diseases;2021-02

5. Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients;Russian Journal of Cardiology;2019-09-08